Invesco’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.98M Sell
152,596
-30,872
-17% -$917K ﹤0.01% 2379
2025
Q4
$5.71M Buy
183,468
+102,676
+127% +$2.82M ﹤0.01% 2186
2025
Q3
$1.74M Buy
80,792
+18,575
+30% +$335K ﹤0.01% 2672
2025
Q2
$870K Buy
62,217
+14,446
+30% +$196K ﹤0.01% 2907
2025
Q1
$644K Buy
47,771
+14,672
+44% +$250K ﹤0.01% 3051
2024
Q4
$635K Buy
33,099
+12,350
+60% +$269K ﹤0.01% 3133
2024
Q3
$472K Buy
20,749
+178
+0.9% +$2.91K ﹤0.01% 3259
2024
Q2
$268K Buy
20,571
+1,841
+10% +$25.5K ﹤0.01% 3538
2024
Q1
$328K Sell
18,730
-126,035
-87% -$2.44M ﹤0.01% 3499
2023
Q4
$3.15M Buy
144,765
+116,932
+420% +$1.85M ﹤0.01% 2456
2023
Q3
$427K Buy
27,833
+8,394
+43% +$160K ﹤0.01% 3277
2023
Q2
$462K Buy
19,439
+789
+4% +$20.2K ﹤0.01% 3283
2023
Q1
$474K Sell
18,650
-175,887
-90% -$5.64M ﹤0.01% 3282
2022
Q4
$5.68M Sell
194,537
-29,779
-13% -$686K ﹤0.01% 2181
2022
Q3
$4.6M Buy
224,316
+213,278
+1,932% +$3.83M ﹤0.01% 2272
2022
Q2
$128K Buy
+11,038
New +$148K ﹤0.01% 3843
2019
Q4
Sell
-1,448
Closed -$16K 3706
2019
Q3
$16K Sell
1,448
-860
-37% -$19K ﹤0.01% 3666
2019
Q2
$71K Buy
+2,308
New +$92.7K ﹤0.01% 3697

Other funds holding VRDN